4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-100532
Director sold 180,409 shares at an average $46.02 ($8,302,088)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-22 | Sale 10b5-1 | −94,908 | $45.82 | $4,348,685 | 805,962 | I |
| Kersten Dirk Director | 2024-08-22 | Sale 10b5-1 | −413 | $46.97 | $19,399 | 805,549 | I |
| Kersten Dirk Director | 2024-08-23 | Sale 10b5-1 | −20,955 | $45.82 | $960,158 | 784,594 | I |
| Kersten Dirk Director | 2024-08-23 | Sale 10b5-1 | −64,133 | $46.37 | $2,973,847 | 720,461 | I |
| Open-market sales · 180,409 sh · avg $46.02 · $8,302,088 | |||||||
Loading xslF345X05/ownership.xml…